⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7366713 | 1.00 | — | — | |
| SCHEMBL31676163 | 0.91 | — | — | |
| SCHEMBL18320895 | 0.82 | — | — | |
| SCHEMBL460688 | 0.82 | — | — | |
| SCHEMBL30401686 | 0.82 | — | — | |
| SCHEMBL460689 | 0.82 | — | — | |
| SCHEMBL31675822 | 0.82 | — | — | |
| SCHEMBL12079525 | 0.80 | — | — | |
| SCHEMBL12079523 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL38657456 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104080335-B | Some chemical entities, composition and method | 钱向平 | 2017-06-09 | — | — | CN | claimed |
| EP-4628519-A1 | ORGANOGERMANIUM(IV) CARBOXYLATES AND MIXTURES OF GERMANIUM CARBOXYLATES WITH ORGANIC ACID ANHYDRIDES AS CATALYSTS | Technische Universität Graz (AT) | 2025-10-08 | — | — | EP | disclosed |
| WO-2025151449-A1 | BIFUNCTIONAL P53-BINDING COMPOUNDS AND USES THEREOF | PHOTYS THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2024218499-A1 | HETEROCYCLIC INHIBITORS OF DNA POLYMERASE THETA FOR THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2024-10-24 | — | — | WO | disclosed |
| EP-4419526-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Artios Pharma Limited (GB) | 2024-08-28 | — | — | EP | disclosed |
| EP-4419527-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Artios Pharma Limited (GB) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023165987-A1 | PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE | Atoms for Cure GmbH (DE) | 2023-09-07 | — | — | WO | disclosed |
| US-20230242546-A1 | SUBSTITUTED PYRIDINES, PYRIDAZINES, PYRIMIDINES, AND 1,2,4-TRIAZINES AS TYK2 INHIBITORS | SUDO BIOSCIENCES LIMITED (GB) | 2023-08-03 | — | — | US | disclosed |
| WO-2023118195-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023067356-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2023-04-27 | — | — | WO | disclosed |
| US-20170217930-A1 | PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES | BRISTOL-MEYERS SQUIBB COMPANY (US) | 2017-08-03 | — | — | US | disclosed |
| CN-104080335-B | Some chemical entities, composition and method | 钱向平 | 2017-06-09 | — | — | CN | disclosed |
| EP-2457913-B1 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | SIGNAL PHARM LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| EP-1973887-B1 | AZA HETEROCYCLICS FOR THE TREATMENT OF MALARIA OR AIDS | IMMUPHARMA FRANCE SA (FR) | 2012-09-19 | — | — | EP | disclosed |
| US-5539104-A | 1,4 Diazocines as fibrinogen antagonists | SMITHKLINE BEECHAM CORP. (US) | 1996-07-23 | — | — | US | disclosed |
| US-5539104-A | 1,4 Diazocines as fibrinogen antagonists | SMITHKLINE BEECHAM CORP. (US) | 1996-07-23 | — | — | US | disclosed |
| EP-0610432-A1 | C8-CYCLIC PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-17 | — | — | EP | disclosed |
| EP-0610432-A1 | C8-CYCLIC PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-17 | — | — | EP | disclosed |
| WO-1993009133-A1 | C8-CYCLIC PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-05-13 | — | — | WO | disclosed |
| WO-1993009133-A1 | C8-CYCLIC PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-05-13 | — | — | WO | disclosed |